FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors
FDA批准摘要:Belzutifan用于治疗von Hippel-Lindau病相关肿瘤
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1054
Fallah, Jaleh; Brave, Michael H; Weinstock, Chana; Mehta, Gautam U; Bradford, Diana; Gittleman, Haley; Bloomquist, Erik W; Charlab, Rosane; Hamed, Salaheldin S; Miller, Claudia P; Dorff, Sarah E; Chambers, Wiley A; Mixter, Bronwyn D; Dinin, Jeannette; Pierce, William F; Ricks, Tiffany K; Tang, Shenghui; Donoghue, Martha; Pazdur, Richard; Amiri-Kordestani, Laleh; Ibrahim, Amna; Beaver, Julia A